22
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Investigation of Carbonic Anhydrase Inhibitory Potency of (Z/E)-alkyl N‘-benzyl-N-(arylsulfonyl)-carbamimidothioates

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 615-627 | Received 01 Dec 2022, Accepted 23 Mar 2023, Published online: 04 May 2023

References

  • Supuran CT . Carbonic anhydrases-an overview. Curr. Pharm. Des.14(7), 603–614 (2008).
  • Supuran CT . Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug. Discov.7(2), 168–181 (2008).
  • Supuran CT , ScozzafavaA. Carbonic anhydrases as targets for medicinal chemistry. Bioorg. Med. Chem.15(13), 4336–4350 (2007).
  • Scozzafava A , OwaT, MastrolorenzoAet al. Anticancer and antiviral sulfonamides. Curr. Med. Chem.10(11), 925–953 (2003).
  • Wan Y , FangG, ChenHet al. Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation. Eur. J. Med. Chem.226, 113837 (2021).
  • Scott KA , NjardarsonJT. Analysis of US FDA-approved drugs containing sulfur atoms. Top. Curr. Chem.376, 1–34 (2019).
  • Gokcen T , GulcinI, OzturkTet al. A class of sulfonamides as carbonic anhydrase I and II inhibitors. J. Enzyme Inhib. Med. Chem.31, 180–188 (2016).
  • Métayer B , MingotA, VulloDet al. New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides. Chem. Comm.49(54), 6015–6017 (2013).
  • Salerno S , AmendolaG, AngeliAet al. Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold. Eur. J. Med. Chem.220, 113490 (2021).
  • Abdoli M , DeLuca V, CapassoCet al. Inhibition studies on carbonic anhydrase isoforms I, II, IX and XII with a series of sulfaguanidines. Chem. Med. Chem.18(6), e202200658 (2023).
  • Abdoli M , AngeliA, BozdagMet al. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5-and 6-sulfonamides. J. Enzyme Inhib. Med. Chem.32(1), 1071–1078 (2017).
  • Abdoli M , BozdagM, AngeliAet al. Benzamide-4-sulfonamides are effective human carbonic anhydrase I, II, VII, and IX inhibitors. Metabolites8(2), 37 (2018).
  • Abdoli M , GiovannuzziS, SupuranCTet al. 4-(3-Alkyl/benzyl-guanidino) benzenesulfonamides as selective carbonic anhydrase VII inhibitors. J. Enzyme Inhib. Med. Chem.37(1), 1568–1576 (2022).
  • Abdoli M , BonardiA, SupuranCTet al. 4-Cyanamidobenzenesulfonamide derivatives: a novel class of human and bacterial carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem.38(1), 156–165 (2023).
  • Ivanova J , AbdoliM, NocentiniAet al. 1,2,3-Benzoxathiazine-2,2-dioxides-effective inhibitors of human carbonic anhydrases. J. Enzyme Inhib. Med. Chem.38(1), 225–238 (2023).
  • Abdoli M , DeLuca V, CapassoCet al. Benzenesulfonamides incorporating hydantoin moieties effectively inhibit eukaryotic and human carbonic anhydrases. Int. J. Mol. Sci.23(22), 14115 (2022).
  • Abdoli M , DeLuca V, CapassoCet al. Novel thiazolone-benzenesulphonamide inhibitors of human and bacterial carbonic anhydrases. J. Enzyme Inhib. Med. Chem.38(1), 2163243 (2023).
  • Abdoli M , BonardiA, SupuranCTet al. Investigation of novel alkyl/benzyl (4-sulphamoylphenyl) carbamimidothioates as carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem.38(1), 2152811 (2023).
  • Ivanova J , AbdoliM, NocentiniAet al. Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II. J. Enzyme Inhib. Med. Chem.38(1), 2170370 (2023).
  • Abdoli M , SupuranCT, ŽalubovskisR. 2-((1H-Benzo[d]imidazol-2-yl)amino)benzo[d]thiazole-6-sulphonamides: a class of carbonic anhydrase II and VII-selective inhibitors. J. Enzyme Inhib. Med. Chem.38(1), 2174981 (2023).
  • Hassan MI , ShajeeB, WaheedAet al. Structure, function and applications of carbonic anhydrase isozymes. Bioorg. Med. Chem.21(6), 1570–1582 (2013).
  • Khalifah RG . The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem.246, 2561–2573 (1971).
  • Vermelho AB , daSilva Cardoso V, RicciJunior Eet al. Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosomacruzi. J. Enzyme Inhib. Med. Chem.33, 139–146 (2018).
  • Nocentini A , CartaF, TancMet al. Deciphering the mechanism of human carbonic anhydrases inhibition with sulfocoumarins: computational and experimental studies. Eur. J. Chem.24, 7840–7844 (2018).
  • Angeli A , CartaF, NocentiniAet al. Response to perspectives on the classical enzyme carbonic anhydrase and the search for inhibitors. Biophys J.120, 178–181 (2021).
  • Bua S , BozdagM, DelPrete Set al. Mono- and di-thiocarbamate inhibition studies of the δ-carbonic anhydrase TweCAδ from the marine diatom Thalassiosiraweissflogii. J. Enzyme Inhib. Med. Chem.33, 707–713 (2018).
  • Ferraroni M , GaspariR, ScozzafavaAet al. Dioxygen, an unexpected carbonic anhydrase ligand. J. Enzyme Inhib. Med. Chem.33, 999–1005 (2018).
  • Pustenko A , NocentiniA, GratteriPet al. The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem.35, 1011–1020 (2020).
  • Akocak S , LolakN, BuaSet al. Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors. J. Enzyme Inhib. Med. Chem.33, 1575–1580 (2018).
  • Nocentini A , BonardiA, GratteriPet al. Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms. J. Enzyme Inhib. Med. Chem.33, 1453–1459 (2018).
  • Nocentini A , TralloriE, SinghSet al. 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles. J. Med. Chem.61, 10860–10874 (2018).
  • Chohan ZH , MunawarA, SupuranCT. Transition metal ion complexes of Schiff-bases. Synthesis, characterization and antibacterial properties. Met. Based Drugs.8, 137–143 (2001).
  • Ivanova J , CartaF, VulloDet al. N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII. Bioorg. Med. Chem.25, 3583–3589 (2017).
  • Supuran CT . Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?J. Enzyme Inhib. Med. Chem.33, 485–495 (2018).
  • Briganti F , PierattelliR, ScozzafavaAet al. Carbonic anhydrase inhibitors. Part 37. Novel classes of carbonic anhydrase inhibitors and their interaction with the native and cobalt-substituted enzyme: kinetic and spectroscopic investigations. Eur. J. Med. Chem.31, 1001–1010 (1996).
  • Pastorekova S , CasiniA, ScozzafavaAet al. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg. Med. Chem. Lett.14, 869–873 (2004).
  • Vullo D , VoipioJ, InnocentiAet al. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett.15, 971–976 (2005).
  • Gieling RG , BaburM, MamnaniLet al. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J. Med. Chem.55, 5591–5600 (2012).
  • Carta F , SupuranCT, ScozzafavaA. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med. Chem.6, 1149–1165 (2014).
  • Sarikaya SB , GülçinI, SupuranCT. Carbonic anhydrase inhibitors: inhibition of human erythrocyte isozymes I and II with a series of phenolic acids. Chem. Biol. Drug Des.75, 515–520 (2010).
  • Yıldırım A , AtmacaU, KeskinAet al. N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II. Bioorg. Med. Chem.23, 2598–2605 (2015).
  • Innocenti A , GülçinI, ScozzafavaAet al. Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg. Med. Chem. Lett.20, 5050–5053 (2010).
  • Schmickl CN , OwensRL, OrrJEet al. Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence. BMJ Open Resp. Res.7(1), e000557 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.